title: The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders.
authors.affiliation: Victor Jiménez-Yuste, Department of Haematology, Autónoma University Madrid and La Paz University Hospital, Pº de la Castellana, 261, 28046 Madrid, Spain, E-mail: vjimenezy@salud.madrid.org.
authors.forename: Víctor
authors.initials: V
authors.lastname: Jiménez-Yuste
authors.forename: Rebecca
authors.initials: R
authors.lastname: Kruse-Jarres
authors.forename: Savita
authors.initials: S
authors.lastname: Rangarajan
authors.forename: Carme
authors.initials: C
authors.lastname: Altisent
mesh_terms: D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy; D006474:Hemorrhagic Disorders / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D010949:Plasma; D014842:von Willebrand Diseases / Q000276:immunology / Q000628:therapy
chemical_list: C078147:F8 protein, human; D005169:Factor VIII